Fredun Pharmaceuticals adds fifth facility in Palghar, expands manufacturing capacity  Keywords: Fredun Pharmaceuticals news,Illustrative image – not actual.

Fredun Pharmaceuticals has announced the establishment of its fifth manufacturing facility in Palghar, marking a significant expansion of its production footprint in the pharmaceutical sector.

The new 40,000 sq. ft. facility is expected to become operational by October 2026 and will strengthen the company’s capabilities across generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products. The expansion plan also includes an additional 50,000 sq. ft. facility under strategic growth initiatives, aimed at further scaling production capacity. The new infrastructure will support key product categories such as veterinary medicines, nutraceutical formulations, and pharmaceutical products, enabling the company to better serve both domestic and international regions. By integrating the new facility with its existing manufacturing units, Fredun Pharmaceuticals aims to improve operational efficiency, enhance production scalability, and meet growing demand in the healthcare sector.

The expansion reinforces the company’s long-term strategy of strengthening its manufacturing base while maintaining high standards of quality, compliance, and innovation.

← All latest storiesBack to top →